The lab-grown meat developer has picked up $47m in its series A round thanks to commitments from investors including Section 32 and Agronomics.
Meatable, a Netherlands-based cultured meat developer based on research at Cambridge and Stanford universities, pocketed $47m in series A financing yesterday from investors including Section 32.
DSM Venturing, the corporate venturing arm of health and nutrition product manufacturer Royal DSM, BlueYard Capital, Agronomics, Humboldt and private investors Rick Klausner, Jeffrey Leiden and Taavet Hinrikus also took part.
Meatable is working on lab-grown meat that relies on pluripotent cells to replicate the natural process of fat and muscle growth, generating cuts of meat within weeks.
The money will allow the company to advance its small-scale production activities and expand its portfolio. Meatable is currently focused on pork and beef, but its technology is adaptable to any livestock-based food product, such as sheep and fish.
Meatable previously secured $7m in seed funding from BlueYard Capital, with contributions from angel investors, in December 2019. The European Commission provided a $3m grant through its Eurostars Programme at the same time.
BlueYard had already led a $3.5m seed round in 2018, when Future Positive Capital, Atlantic Food Labs, Backed VC and several angel investors also invested.
